DC Circ. Opens Door For Stem Cell Regulation By FDA
When is the use of autologous stem cells in a medical procedure subject to regulation by the U.S. Food and Drug Administration? This question was at the forefront of a statutory...To view the full article, register now.
Already a subscriber? Click here to view full article